JP2021523117A5 - - Google Patents

Info

Publication number
JP2021523117A5
JP2021523117A5 JP2020561727A JP2020561727A JP2021523117A5 JP 2021523117 A5 JP2021523117 A5 JP 2021523117A5 JP 2020561727 A JP2020561727 A JP 2020561727A JP 2020561727 A JP2020561727 A JP 2020561727A JP 2021523117 A5 JP2021523117 A5 JP 2021523117A5
Authority
JP
Japan
Prior art keywords
amino acid
seq
acid sequence
composition
hvr
Prior art date
Application number
JP2020561727A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2019213468A5 (https=
JP2021523117A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/030523 external-priority patent/WO2019213468A1/en
Publication of JP2021523117A publication Critical patent/JP2021523117A/ja
Publication of JP2021523117A5 publication Critical patent/JP2021523117A5/ja
Publication of JPWO2019213468A5 publication Critical patent/JPWO2019213468A5/ja
Priority to JP2024022749A priority Critical patent/JP2024045612A/ja
Withdrawn legal-status Critical Current

Links

JP2020561727A 2018-05-04 2019-05-03 慢性蕁麻疹を処置するための方法および組成物 Withdrawn JP2021523117A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024022749A JP2024045612A (ja) 2018-05-04 2024-02-19 慢性蕁麻疹を処置するための方法および組成物

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US201862667242P 2018-05-04 2018-05-04
US62/667,242 2018-05-04
US201962788719P 2019-01-04 2019-01-04
US62/788,719 2019-01-04
US201962797817P 2019-01-28 2019-01-28
US62/797,817 2019-01-28
US201962803211P 2019-02-08 2019-02-08
US62/803,211 2019-02-08
US201962806657P 2019-02-15 2019-02-15
US62/806,657 2019-02-15
PCT/US2019/030523 WO2019213468A1 (en) 2018-05-04 2019-05-03 Methods and compositions for treating chronic urticaria

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024022749A Division JP2024045612A (ja) 2018-05-04 2024-02-19 慢性蕁麻疹を処置するための方法および組成物

Publications (3)

Publication Number Publication Date
JP2021523117A JP2021523117A (ja) 2021-09-02
JP2021523117A5 true JP2021523117A5 (https=) 2022-05-13
JPWO2019213468A5 JPWO2019213468A5 (https=) 2022-05-13

Family

ID=68386174

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020561727A Withdrawn JP2021523117A (ja) 2018-05-04 2019-05-03 慢性蕁麻疹を処置するための方法および組成物
JP2024022749A Pending JP2024045612A (ja) 2018-05-04 2024-02-19 慢性蕁麻疹を処置するための方法および組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024022749A Pending JP2024045612A (ja) 2018-05-04 2024-02-19 慢性蕁麻疹を処置するための方法および組成物

Country Status (11)

Country Link
US (1) US20210246205A1 (https=)
EP (1) EP3788078A4 (https=)
JP (2) JP2021523117A (https=)
KR (1) KR20210005245A (https=)
CN (1) CN112384535A (https=)
AU (1) AU2019262167A1 (https=)
BR (1) BR112020022236A2 (https=)
CA (1) CA3099338A1 (https=)
MX (1) MX2020011377A (https=)
SG (1) SG11202010911WA (https=)
WO (1) WO2019213468A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200016232A (ko) 2017-05-05 2020-02-14 알라코스 인크. 알레르기성 안구 질환을 치료하기 위한 방법 및 조성물
JP2023541217A (ja) * 2020-07-10 2023-09-29 シャンハイ ジェミンケア ファーマシューティカル カンパニー,リミティド 抗IgE改変抗体及びその適用
KR102803012B1 (ko) * 2022-08-11 2025-04-30 오씨아이 주식회사 석유계 고연화점 피치의 제조방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201603127WA (en) * 2013-10-23 2016-05-30 Genentech Inc Methods of diagnosing and treating eosinophilic disorders
KR102311761B1 (ko) * 2013-12-09 2021-10-13 알라코스 인크. 항-Siglec-8 항체 및 그의 사용 방법
CA2939931C (en) * 2014-02-28 2025-04-22 Allakos Inc. METHODS AND COMPOSITIONS FOR TREATING DISEASES ASSOCIATED WITH SIGLEC8
US10604577B2 (en) * 2015-10-22 2020-03-31 Allakos Inc. Methods and compositions for treating systemic mastocytosis

Similar Documents

Publication Publication Date Title
US11512132B2 (en) Anti-PD-L1 antibodies and their use as therapeutics and diagnostics
JP6454678B2 (ja) pH範囲で結合性が異なる薬物動態改善のための抗TFPI抗体変異体
CN110662768B (zh) 治疗性抗cd40配体抗体
JP2020503260A5 (https=)
CN102027017A (zh) 一种治疗疾病的试剂
WO2007117600A2 (en) Combination therapy for treating autoimmune diseases
CN102027016A (zh) 一种治疗疾病的试剂
US20240092875A1 (en) Sars-cov-2 antibodies for treatment and prevention of covid-19
JP2021523117A5 (https=)
WO2021110107A1 (en) COMBINATION OF BISPECIFIC FUSION PROTEIN AND ANTI-Her2 ANTIBODY FOR TUMOR TREATMENT
JP2020518638A5 (https=)
JPWO2019213468A5 (https=)
AU2023282504A1 (en) Igf1r antibodies
US20210371519A1 (en) Suppressing IgE-Mediated Allergy by Desensitization with Monovalent Anti-FCeR1a Monoclonal Antibody
HK40015379A (en) Therapeutic anti-cd40 ligand antibodies
HK40005909A (en) Anti-pd-l1 antibodies and their use as therapeutics and diagnostics
HK40005909B (en) Anti-pd-l1 antibodies and their use as therapeutics and diagnostics
JPWO2021081411A5 (https=)